Rapid results drive faster intervention resulting in improved patient outcomes. At Nanōmix, we understand that testing patients at the point of first contact can reduce the time to diagnosis, improve patient outcomes and reduce a significant amount of excess costs.
Designed for emergency medical and other point-of-care needs, the Nanōmix eLab uses a single patient blood, plasma, or serum sample, to provide actionable results within 10 minutes. The device is simple to operate via an intuitive user interface on a color touch screen. The system uses a proprietary nano-biosensor formatted into a disposable microfluidics test cartridge for high quality, reliable performance. All test functions are controlled and automatically processed by the device. The robust system design supports use in almost any setting, inside or outside of the traditional laboratory environment.
Sepsis is the body’s overwhelming response to infection, which can lead to tissue damage, organ failure, and death. It is a leading cause of death in the United States.
Current tests for sepsis can take hours or days, are costly, and require the use of multiple instruments that are most often operated by skilled technicians within a central hospital laboratory. Rapid diagnosis and aggressive clinical intervention are critical for patients to survive sepsis, and even short delays in sepsis identification and administration of treatment can negatively impact patient outcomes and increase mortality.
The Nanōmix test panel incorporates enzymatic and immuno-assays for three key sepsis markers. The test is performed within 10 minutes and can be used at the first point of contact between a patient and the healthcare provider.
If you would like to collaborate with us this area please Contact Us.